64x Bio

We’re excited to share the news of our $55M series A today! https://lnkd.in/giZcFMyU

Academic innovators have driven groundbreaking technologies like CRISPR, gene therapies, CAR T, and mRNA. The handoff to industry is allowing such discoveries to reach patients, but some of these transformations must overcome limitations that cap their use. At #BioCenturyGrandRounds, the Modality Groundbreaker Session spotlighted potential solutions and guide drug developers on prioritizing innovations for efficient patient treatment: ➤ The heyday of AAV engineering is here: Will it deliver? ➤ The regenerative moment: Are iPSCs poised to reshape the cell therapy toolbox? ➤ Maximizing the impact of gene editing: Incremental improvements, or leaps to newer technologies? ➤ Souping up cancer cell therapies: Is the juice worth the squeeze? Registration is available on-site at Four Seasons Nashville, or register for a digital pass to watch recordings of the sessions at https://lnkd.in/gmhZ75vm. Thank you to our Grand Rounds II: Modality Groundbreakers panelists and moderators: Andrew Bellinger, Verve Therapeutics Zandy Forbes, MeiraGTx Erin Kimbrel, Astellas Pharma Samuel Lynch, Vanderbilt University Medical Center Marinna Madrid, PhD, Cellino Biotech Clare Murray, Life Edit Therapeutics Greg Newby, The Johns Hopkins University Stephanie Oestreich, myeloma investment fund Deborah Palestrant, 5AM Ventures Becky Pferdehirt, PhD, Andreessen Horowitz Lexi Rovner, 64x Bio Krishnendu Roy, Vanderbilt University Florencia Pereyra Segal, MPM BioImpact Henning Stennicke, Spur Therapeutics

🥕🥕 From Tunisia to the heart of Y Combinator, I had a blast learning from Lexi Rovner (64x Bio), Alex Levy (Atmo), Banks Hunter (Charge Robotics), and the awesome Jared Friedman. Grateful for the opportunity to learn from their journey in building deep tech startups. #YC #YCombinator #deeptech #startup

Our CEO Lexi Rovner will be speaking on a panel at the State of Cell and Gene Therapy virtual conference today, hosted by Genetic Engineering & Biotechnology News. 🧬 The panel will be moderated by Jonathan D. Grinstein, PhD. Tune in below: https://lnkd.in/eUd6CUmd

I'm beyond thrilled to announce Northwestern's Querrey InQbation Lab FoundHer Stories 2024 series highlighting inspiring women scientist entrepreneurs who have spun out startups from their academic research. Join us for virtual monthly fireside chats with these trailblazing entrepreneurs as they share their startup stories and advice to first-time technical founders. So honored to chat with these rockstars! Tina Boville (Aralez Bio), Peyton Greenside (BigHat Biosciences), Lexi Rovner (64x Bio), Elizabeth Wood (JURA Bio, Inc.), Marinna Madrid, PhD (Cellino), Janice Chen (Mammoth Biosciences), Mariana Matus, PhD (Biobot Analytics), Nishita Deka (Sonera) Register here: https://lnkd.in/efvCGDgC #startupstories #womenentrepreneurs #womeninstem #academicinnovation

The 64x Bio team is in San Francisco for the J.P. Morgan 42nd Annual Healthcare Conference, and is excited to connect with partners, colleagues, and friends!   If you're in San Francisco for the conference, we're looking forward to discussing our latest progress, our plans for 2024, and exploring new partnership opportunities. Reach out to us at [email protected].   The following members of our team are attending:   Lexi Rovner, CEO & Co-founder Farhad (Seyyedhassan) Paylakhi, VP of R&D & Co-founder   We're looking forward to seeing you here!